Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan M Roden

Circulation

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Circulation|January 26, 2005
An underrecognized challenge in evaluating postmarketing drug safetyDan M Roden
Circulation|September 4, 2008
Repolarization reserve: a moving targetDan M Roden
Circulation|October 26, 2018
Growing Pains in Cardiovascular GeneticsDan M Roden
Circulation|December 24, 2003
Cardiovascular pharmacogenomicsDan M Roden
Circulation|April 7, 2005
The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval processDan M Roden, Robert Temple
Circulation|September 8, 2005
Protecting the heart against arrhythmias: potassium current physiology and repolarization reserveDan M Roden, Tao Yang
Circulation|April 29, 2009
Clopidogrel and the concept of high-risk pharmacokineticsDan M Roden, C Michael Stein
Circulation|March 23, 2013
Stem cell-derived cardiomyocytes as a tool for studying proarrhythmia: a better canary in the coal mine?Dan M Roden, Charles C Hong
Circulation|January 10, 2014
Dantrolene: from better bacon to a treatment for ventricular fibrillationDan M Roden, Björn C Knollmann
Circulation|June 30, 2010
Responding to the clopidogrel warning by the US food and drug administration: real life is complicatedDan M Roden, Alan R Shuldiner
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Circulation|January 26, 2005
An underrecognized challenge in evaluating postmarketing drug safetyDan M Roden
Circulation|September 4, 2008
Repolarization reserve: a moving targetDan M Roden
Circulation|October 26, 2018
Growing Pains in Cardiovascular GeneticsDan M Roden
Circulation|December 24, 2003
Cardiovascular pharmacogenomicsDan M Roden
Circulation|April 7, 2005
The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval processDan M Roden, Robert Temple
Circulation|September 8, 2005
Protecting the heart against arrhythmias: potassium current physiology and repolarization reserveDan M Roden, Tao Yang
Circulation|April 29, 2009
Clopidogrel and the concept of high-risk pharmacokineticsDan M Roden, C Michael Stein
Circulation|March 23, 2013
Stem cell-derived cardiomyocytes as a tool for studying proarrhythmia: a better canary in the coal mine?Dan M Roden, Charles C Hong
Circulation|January 10, 2014
Dantrolene: from better bacon to a treatment for ventricular fibrillationDan M Roden, Björn C Knollmann
Circulation|June 30, 2010
Responding to the clopidogrel warning by the US food and drug administration: real life is complicatedDan M Roden, Alan R Shuldiner
Pageof 7